® Timoptol, Trusopt, Cosopt & Saflutan are registered trademarks of Mundipharma AG in UAE and are either registered trademarks or trademarks in other countries.
Please refer to individual countries for full local prescribing information and indications as approved by relative health authorities
* Not all products or indications are available in all countries. Products are currently under registrations across Middle East, Turkey and Africa Region and subject to approval according to local laws and regulations.
Please refer to your local representative office and the locally approved prescribing information for more details on the product and indications. Furthermore, Mundipharma Middle East FZLLC provides the information for readers from many countries in the ME region as of this date and does not undertake any obligation to update any forward-looking statements contained in this newsletter as a result of new information, future events or otherwise.
1 Quigley et al. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262–267.